Immune Cell Memories Boost Blood Clot Risk After Inflammation
- understanding the complex relationship between inflammation, infection, and the increased risk of venous thromboembolism (VTE) is crucial for developing effective treatments and preventative measures.
- The connection between inflammation,infection,and venous thrombosis has been acknowledged for a considerable time.
- These interconnected systems are designed to mount an effective response to injury and pathogen invasion.
The Interplay of Inflammation, Infection, and Venous Thromboembolism
Table of Contents
- The Interplay of Inflammation, Infection, and Venous Thromboembolism
- Inflammation, Infection, and Blood Clots: Understanding the Link to Venous Thromboembolism (VTE)
- Q&A: Inflammation, Infection, and VTE
- What is the connection between inflammation, infection, and venous thromboembolism (VTE)?
- How do platelets contribute to thromboinflammation and increase VTE risk?
- Which inflammatory conditions are specifically linked to an increased risk of thrombotic events?
- What is “trained immunity” and how does it relate to blood clots?
- What are the potential new treatments targeting inflammation to prevent blood clots?
- Can you summarize the link between Inflammation, Infection, and VTE?
- What should individuals with inflammatory conditions do to lower their VTE risk?
- Q&A: Inflammation, Infection, and VTE
Published: 2025-03-11
understanding the complex relationship between inflammation, infection, and the increased risk of venous thromboembolism (VTE) is crucial for developing effective treatments and preventative measures.
The Long-Recognized association
The connection between inflammation,infection,and venous thrombosis has been acknowledged for a considerable time. Though, the intricate mechanisms through which the immune and coagulation systems interact and regulate each other are only recently beginning to be understood.
These interconnected systems are designed to mount an effective response to injury and pathogen invasion. though, dysregulation can lead to detrimental outcomes.
The association between inflammation, infection, and venous thrombosis has long been recognized; yet, only in the last decades have we begun to understand the mechanisms through which the immune and coagulation systems interact and reciprocally regulate one another.
Platelets and Thromboinflammation
Platelets play a significant role in the development and progression of inflammatory diseases, which are often associated with a higher risk of VTE. These conditions include:
- Psoriasis
- Cancer metastases
- Transplant rejection
- Infectious diseases such as sepsis
- Malaria
- dengue
- SARS-CoV-2 infection
During thromboinflammation, platelets contribute considerably to the process.
Platelets contribute to the pathogenesis and sequelae of inflammatory diseases that are associated with a higher risk of VTE, including psoriasis, cancer metastases, transplant rejection, and infectious diseases such as sepsis, malaria, dengue and SARS-CoV-2 infection.
Platelets not only provide a surface for coagulation but also release inflammatory mediators, further exacerbating the thrombotic and inflammatory processes.
Inflammatory Conditions and Thrombotic Events
various inflammatory conditions are linked to an increased risk of thrombotic events. These include:
- Infection
- chronic autoimmune diseases
- Clonal haematopoiesis of indeterminate potential
Understanding these associations is vital for identifying individuals at higher risk and implementing preventive strategies.
Inflammatory conditions such as infection, chronic autoimmune diseases and clonal haematopoiesis of indeterminate potential are associated with an increased risk of thrombotic events, providing …
Irish Research Sheds Light on Inflammation and Blood Clots
New research from Ireland offers insights into why individuals with inflammatory diseases face a heightened risk of blood clots. The study, conducted by scientists at RCSI, FutureNeuro, Trinity College Dublin, and Children’s Health Ireland, revealed that white blood cells with a “memory” of past inflammation tend to overreact, increasing the likelihood of future complications.
This research highlights the concept of “trained immunity,” where immune cells remember past encounters with inflammation or infection,leading to a more aggressive response to future threats.
Certain immune cells can ‘remember’ past encounters with inflammation or infection, a concept known as trained immunity. This memory allows them to respond more aggressively to future threats.
The study found that this heightened response can have unintended consequences, such as promoting blood clotting.
Our study found that this heightened response can have unintended consequences. When these myeloid cells in the immune system have been trained by prior exposure to specific inflammatory agents, they also become more likely to promote blood clotting.
The findings suggest that periods of inflammation during disease could lead to the generation of immune cells with increased clotting activity long after the original inflammatory event.
The findings suggest that periods of inflammation during disease could cause the generation of immune cells with increased clotting activity long after the original inflammatory event has taken place.
Potential for Targeted Treatments
The study’s authors suggest that their findings could pave the way for targeted treatments to prevent or manage conditions where the immune system and clotting system are overly active. This could lead to new therapeutic strategies for individuals with inflammatory diseases who are at risk of blood clot-related complications.
If this was translated to humans, the study suggests that while trained immunity can boost the body’s defense against infections, it may also contribute to the risk of blood clot-related complications in individuals with inflammatory disease.
Inflammation, Infection, and Blood Clots: Understanding the Link to Venous Thromboembolism (VTE)
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), poses a importent health risk.Understanding the intricate relationship between inflammation, infection, and VTE is crucial for developing effective prevention and treatment strategies. This Q&A explores this complex interplay, drawing on recent research and established knowledge.
Q&A: Inflammation, Infection, and VTE
What is the connection between inflammation, infection, and venous thromboembolism (VTE)?
The association between inflammation, infection, and venous thrombosis has long been recognized. The immune and coagulation systems interact and reciprocally regulate one another. While these interconnected systems are designed to mount an effective response to injury and pathogen invasion, dysregulation can lead to detrimental outcomes, including an increased risk of VTE.
How do platelets contribute to thromboinflammation and increase VTE risk?
Platelets contribute to the development and progression of inflammatory diseases, which are often associated with a higher risk of VTE. during thromboinflammation, platelets not only provide a surface for coagulation but also release inflammatory mediators, further exacerbating the thrombotic and inflammatory processes. this dual role makes platelets a key player in the link between inflammation and VTE.
Which inflammatory conditions are specifically linked to an increased risk of thrombotic events?
Several inflammatory conditions are associated with an increased risk of thrombotic events, including:
Infections (e.g., sepsis, malaria, dengue, SARS-CoV-2)
Chronic autoimmune diseases
Clonal hematopoiesis of indeterminate potential (CHIP)
What is “trained immunity” and how does it relate to blood clots?
“Trained immunity” is a concept where immune cells “remember” past encounters with inflammation or infection, leading to a more aggressive response to future threats. While beneficial for fighting infections, this heightened response can have unintended consequences, such as promoting blood clotting. Research suggests that periods of inflammation during disease could lead to the generation of immune cells with increased clotting activity long after the original inflammatory event.
What are the potential new treatments targeting inflammation to prevent blood clots?
Research suggests that understanding the interplay between inflammation and blood clotting could pave the way for targeted treatments. This could lead to new therapeutic strategies for individuals with inflammatory diseases who are at risk of blood clot-related complications, to prevent or manage conditions where the immune system and clotting system are overly active.
Can you summarize the link between Inflammation, Infection, and VTE?
| Factor | Role in VTE |
| —————– | —————————————————————————————————————————————————— |
| Inflammation | Contributes to the activation of the coagulation system, increasing the risk of blood clot formation. |
| Infection | Can trigger inflammatory responses that activate the coagulation cascade, leading to a higher risk of VTE. |
| Platelets | Play a central role in thromboinflammation by both promoting coagulation and releasing inflammatory mediators, exacerbating both processes. |
| Trained Immunity | Heightened immune response to inflammation can unintentionally promote blood clotting |
What should individuals with inflammatory conditions do to lower their VTE risk?
Individuals with inflammatory conditions should consult with their healthcare provider to assess their individual risk of VTE. Preventative strategies may include:
Managing underlying inflammatory conditions.
Lifestyle modifications such as maintaining a healthy weight and regular exercise.
In certain specific cases, prophylactic anticoagulation might potentially be considered, especially during periods of acute inflammation or infection.